nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—CYP2B6—Raloxifene—osteoporosis	0.148	0.19	CbGbCtD
Benzphetamine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.143	0.183	CbGbCtD
Benzphetamine—CYP2B6—Cholecalciferol—osteoporosis	0.114	0.146	CbGbCtD
Benzphetamine—CYP3A4—Estropipate—osteoporosis	0.0682	0.0873	CbGbCtD
Benzphetamine—CYP3A4—Calcitriol—osteoporosis	0.0682	0.0873	CbGbCtD
Benzphetamine—CYP3A4—Ergocalciferol—osteoporosis	0.0545	0.0698	CbGbCtD
Benzphetamine—CYP3A4—Raloxifene—osteoporosis	0.0455	0.0582	CbGbCtD
Benzphetamine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0439	0.0562	CbGbCtD
Benzphetamine—CYP3A4—Cholecalciferol—osteoporosis	0.0351	0.0449	CbGbCtD
Benzphetamine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0323	0.0413	CbGbCtD
Benzphetamine—CYP3A4—Estradiol—osteoporosis	0.0283	0.0362	CbGbCtD
Benzphetamine—Psychotic disorder—Calcitriol—osteoporosis	0.0032	0.0188	CcSEcCtD
Benzphetamine—Anorexia—Calcium Acetate—osteoporosis	0.00288	0.0169	CcSEcCtD
Benzphetamine—Decreased appetite—Calcium Acetate—osteoporosis	0.00263	0.0154	CcSEcCtD
Benzphetamine—Psychotic disorder—Pamidronate—osteoporosis	0.00256	0.015	CcSEcCtD
Benzphetamine—Anorexia—Ergocalciferol—osteoporosis	0.00255	0.0149	CcSEcCtD
Benzphetamine—Sweating—Raloxifene—osteoporosis	0.0025	0.0147	CcSEcCtD
Benzphetamine—Sweating—Ibandronate—osteoporosis	0.00248	0.0145	CcSEcCtD
Benzphetamine—Decreased appetite—Ergocalciferol—osteoporosis	0.00232	0.0136	CcSEcCtD
Benzphetamine—Hypersensitivity—Calcium Acetate—osteoporosis	0.00223	0.0131	CcSEcCtD
Benzphetamine—Diarrhoea—Calcium Acetate—osteoporosis	0.00207	0.0121	CcSEcCtD
Benzphetamine—Dizziness—Calcium Acetate—osteoporosis	0.002	0.0117	CcSEcCtD
Benzphetamine—Palpitations—Estropipate—osteoporosis	0.00186	0.0109	CcSEcCtD
Benzphetamine—Agitation—Calcitriol—osteoporosis	0.00182	0.0107	CcSEcCtD
Benzphetamine—Nausea—Calcium Acetate—osteoporosis	0.0018	0.0105	CcSEcCtD
Benzphetamine—Palpitations—Ibandronate—osteoporosis	0.00178	0.0105	CcSEcCtD
Benzphetamine—Dyspepsia—Etidronic acid—osteoporosis	0.00175	0.0103	CcSEcCtD
Benzphetamine—Hyperhidrosis—Raloxifene—osteoporosis	0.00161	0.00944	CcSEcCtD
Benzphetamine—Hyperhidrosis—Ibandronate—osteoporosis	0.00159	0.00934	CcSEcCtD
Benzphetamine—Nausea—Ergocalciferol—osteoporosis	0.00159	0.00931	CcSEcCtD
Benzphetamine—Urticaria—Etidronic acid—osteoporosis	0.00158	0.00925	CcSEcCtD
Benzphetamine—Insomnia—Estropipate—osteoporosis	0.00155	0.00911	CcSEcCtD
Benzphetamine—Anorexia—Calcitriol—osteoporosis	0.00154	0.00902	CcSEcCtD
Benzphetamine—Dyspepsia—Estropipate—osteoporosis	0.00151	0.00887	CcSEcCtD
Benzphetamine—Insomnia—Raloxifene—osteoporosis	0.0015	0.00883	CcSEcCtD
Benzphetamine—Insomnia—Ibandronate—osteoporosis	0.00149	0.00874	CcSEcCtD
Benzphetamine—Dyspepsia—Alendronate—osteoporosis	0.00149	0.00874	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Estropipate—osteoporosis	0.00148	0.0087	CcSEcCtD
Benzphetamine—Dyspepsia—Raloxifene—osteoporosis	0.00146	0.00859	CcSEcCtD
Benzphetamine—Hypersensitivity—Etidronic acid—osteoporosis	0.00146	0.00858	CcSEcCtD
Benzphetamine—Insomnia—Calcitriol—osteoporosis	0.00146	0.00855	CcSEcCtD
Benzphetamine—Agitation—Pamidronate—osteoporosis	0.00145	0.00852	CcSEcCtD
Benzphetamine—Dyspepsia—Ibandronate—osteoporosis	0.00145	0.00851	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00144	0.00843	CcSEcCtD
Benzphetamine—Decreased appetite—Ibandronate—osteoporosis	0.00143	0.0084	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00142	0.00834	CcSEcCtD
Benzphetamine—Decreased appetite—Calcitriol—osteoporosis	0.0014	0.00822	CcSEcCtD
Benzphetamine—Urticaria—Estropipate—osteoporosis	0.00136	0.008	CcSEcCtD
Benzphetamine—Diarrhoea—Etidronic acid—osteoporosis	0.00136	0.00797	CcSEcCtD
Benzphetamine—Tremor—Zoledronate—osteoporosis	0.00135	0.00794	CcSEcCtD
Benzphetamine—Urticaria—Alendronate—osteoporosis	0.00134	0.00788	CcSEcCtD
Benzphetamine—Agitation—Zoledronate—osteoporosis	0.00133	0.00779	CcSEcCtD
Benzphetamine—Urticaria—Ibandronate—osteoporosis	0.00131	0.00768	CcSEcCtD
Benzphetamine—Urticaria—Calcitriol—osteoporosis	0.00128	0.00751	CcSEcCtD
Benzphetamine—Palpitations—Zoledronate—osteoporosis	0.00128	0.00749	CcSEcCtD
Benzphetamine—Hypersensitivity—Estropipate—osteoporosis	0.00127	0.00742	CcSEcCtD
Benzphetamine—Tachycardia—Pamidronate—osteoporosis	0.00126	0.00739	CcSEcCtD
Benzphetamine—Hyperhidrosis—Pamidronate—osteoporosis	0.00125	0.00732	CcSEcCtD
Benzphetamine—Hypersensitivity—Alendronate—osteoporosis	0.00125	0.00731	CcSEcCtD
Benzphetamine—Headache—Etidronic acid—osteoporosis	0.00124	0.0073	CcSEcCtD
Benzphetamine—Anorexia—Pamidronate—osteoporosis	0.00123	0.00722	CcSEcCtD
Benzphetamine—Palpitations—Conjugated Estrogens—osteoporosis	0.00123	0.00721	CcSEcCtD
Benzphetamine—Insomnia—Risedronate—osteoporosis	0.00123	0.0072	CcSEcCtD
Benzphetamine—Hypersensitivity—Ibandronate—osteoporosis	0.00121	0.00712	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.0012	0.00705	CcSEcCtD
Benzphetamine—Dyspepsia—Risedronate—osteoporosis	0.00119	0.00701	CcSEcCtD
Benzphetamine—Hypersensitivity—Calcitriol—osteoporosis	0.00119	0.00697	CcSEcCtD
Benzphetamine—Nausea—Etidronic acid—osteoporosis	0.00118	0.00692	CcSEcCtD
Benzphetamine—Diarrhoea—Estropipate—osteoporosis	0.00117	0.00689	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00117	0.00687	CcSEcCtD
Benzphetamine—Insomnia—Pamidronate—osteoporosis	0.00117	0.00685	CcSEcCtD
Benzphetamine—Diarrhoea—Alendronate—osteoporosis	0.00116	0.00679	CcSEcCtD
Benzphetamine—Tachycardia—Zoledronate—osteoporosis	0.00115	0.00675	CcSEcCtD
Benzphetamine—Hyperhidrosis—Zoledronate—osteoporosis	0.00114	0.00668	CcSEcCtD
Benzphetamine—Diarrhoea—Raloxifene—osteoporosis	0.00114	0.00668	CcSEcCtD
Benzphetamine—Dyspepsia—Pamidronate—osteoporosis	0.00114	0.00666	CcSEcCtD
Benzphetamine—Dizziness—Estropipate—osteoporosis	0.00114	0.00666	CcSEcCtD
Benzphetamine—Diarrhoea—Ibandronate—osteoporosis	0.00113	0.00661	CcSEcCtD
Benzphetamine—Anorexia—Zoledronate—osteoporosis	0.00112	0.00659	CcSEcCtD
Benzphetamine—Decreased appetite—Pamidronate—osteoporosis	0.00112	0.00658	CcSEcCtD
Benzphetamine—Dizziness—Alendronate—osteoporosis	0.00112	0.00656	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00111	0.00654	CcSEcCtD
Benzphetamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00111	0.0065	CcSEcCtD
Benzphetamine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00111	0.00649	CcSEcCtD
Benzphetamine—Diarrhoea—Calcitriol—osteoporosis	0.0011	0.00647	CcSEcCtD
Benzphetamine—Dizziness—Raloxifene—osteoporosis	0.0011	0.00645	CcSEcCtD
Benzphetamine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.0011	0.00644	CcSEcCtD
Benzphetamine—Dizziness—Ibandronate—osteoporosis	0.00109	0.00639	CcSEcCtD
Benzphetamine—Anorexia—Conjugated Estrogens—osteoporosis	0.00108	0.00635	CcSEcCtD
Benzphetamine—Urticaria—Risedronate—osteoporosis	0.00108	0.00633	CcSEcCtD
Benzphetamine—Headache—Estropipate—osteoporosis	0.00108	0.00631	CcSEcCtD
Benzphetamine—Insomnia—Zoledronate—osteoporosis	0.00107	0.00625	CcSEcCtD
Benzphetamine—Headache—Alendronate—osteoporosis	0.00106	0.00622	CcSEcCtD
Benzphetamine—Tremor—Estradiol—osteoporosis	0.00104	0.00612	CcSEcCtD
Benzphetamine—Headache—Raloxifene—osteoporosis	0.00104	0.00611	CcSEcCtD
Benzphetamine—Dyspepsia—Zoledronate—osteoporosis	0.00104	0.00609	CcSEcCtD
Benzphetamine—Headache—Ibandronate—osteoporosis	0.00103	0.00605	CcSEcCtD
Benzphetamine—Insomnia—Conjugated Estrogens—osteoporosis	0.00103	0.00602	CcSEcCtD
Benzphetamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00103	0.00602	CcSEcCtD
Benzphetamine—Decreased appetite—Zoledronate—osteoporosis	0.00102	0.00601	CcSEcCtD
Benzphetamine—Agitation—Estradiol—osteoporosis	0.00102	0.006	CcSEcCtD
Benzphetamine—Nausea—Estropipate—osteoporosis	0.00102	0.00598	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00102	0.00597	CcSEcCtD
Benzphetamine—Headache—Calcitriol—osteoporosis	0.00101	0.00593	CcSEcCtD
Benzphetamine—Nausea—Alendronate—osteoporosis	0.001	0.00589	CcSEcCtD
Benzphetamine—Hypersensitivity—Risedronate—osteoporosis	0.001	0.00587	CcSEcCtD
Benzphetamine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000999	0.00586	CcSEcCtD
Benzphetamine—Nausea—Raloxifene—osteoporosis	0.000988	0.0058	CcSEcCtD
Benzphetamine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000986	0.00579	CcSEcCtD
Benzphetamine—Palpitations—Estradiol—osteoporosis	0.000983	0.00577	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00098	0.00575	CcSEcCtD
Benzphetamine—Nausea—Ibandronate—osteoporosis	0.000978	0.00574	CcSEcCtD
Benzphetamine—Nausea—Calcitriol—osteoporosis	0.000957	0.00562	CcSEcCtD
Benzphetamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000952	0.00559	CcSEcCtD
Benzphetamine—Hypersensitivity—Pamidronate—osteoporosis	0.00095	0.00558	CcSEcCtD
Benzphetamine—Toremifene—ESR1—osteoporosis	0.000946	0.274	CrCbGaD
Benzphetamine—Urticaria—Zoledronate—osteoporosis	0.000936	0.00549	CcSEcCtD
Benzphetamine—Diarrhoea—Risedronate—osteoporosis	0.000929	0.00545	CcSEcCtD
Benzphetamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00092	0.0054	CcSEcCtD
Benzphetamine—Urticaria—Conjugated Estrogens—osteoporosis	0.000901	0.00529	CcSEcCtD
Benzphetamine—Dizziness—Risedronate—osteoporosis	0.000897	0.00527	CcSEcCtD
Benzphetamine—Tachycardia—Estradiol—osteoporosis	0.000886	0.0052	CcSEcCtD
Benzphetamine—Diarrhoea—Pamidronate—osteoporosis	0.000883	0.00518	CcSEcCtD
Benzphetamine—Hyperhidrosis—Estradiol—osteoporosis	0.000878	0.00515	CcSEcCtD
Benzphetamine—Headache—Ethinyl Estradiol—osteoporosis	0.000872	0.00512	CcSEcCtD
Benzphetamine—Hypersensitivity—Zoledronate—osteoporosis	0.000868	0.00509	CcSEcCtD
Benzphetamine—Dizziness—Pamidronate—osteoporosis	0.000853	0.00501	CcSEcCtD
Benzphetamine—Headache—Risedronate—osteoporosis	0.00085	0.00499	CcSEcCtD
Benzphetamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000836	0.00491	CcSEcCtD
Benzphetamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000827	0.00485	CcSEcCtD
Benzphetamine—Insomnia—Estradiol—osteoporosis	0.000821	0.00482	CcSEcCtD
Benzphetamine—Headache—Pamidronate—osteoporosis	0.000808	0.00474	CcSEcCtD
Benzphetamine—Diarrhoea—Zoledronate—osteoporosis	0.000806	0.00473	CcSEcCtD
Benzphetamine—Nausea—Risedronate—osteoporosis	0.000806	0.00473	CcSEcCtD
Benzphetamine—Dyspepsia—Estradiol—osteoporosis	0.000799	0.00469	CcSEcCtD
Benzphetamine—Decreased appetite—Estradiol—osteoporosis	0.000789	0.00463	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000784	0.0046	CcSEcCtD
Benzphetamine—Dizziness—Zoledronate—osteoporosis	0.000779	0.00457	CcSEcCtD
Benzphetamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000776	0.00456	CcSEcCtD
Benzphetamine—Nausea—Pamidronate—osteoporosis	0.000766	0.0045	CcSEcCtD
Benzphetamine—Dizziness—Conjugated Estrogens—osteoporosis	0.00075	0.0044	CcSEcCtD
Benzphetamine—Headache—Zoledronate—osteoporosis	0.000738	0.00433	CcSEcCtD
Benzphetamine—Urticaria—Estradiol—osteoporosis	0.000721	0.00423	CcSEcCtD
Benzphetamine—Headache—Conjugated Estrogens—osteoporosis	0.000711	0.00417	CcSEcCtD
Benzphetamine—Nausea—Zoledronate—osteoporosis	0.0007	0.00411	CcSEcCtD
Benzphetamine—Levomethadyl Acetate—CYP19A1—osteoporosis	0.000694	0.201	CrCbGaD
Benzphetamine—Nausea—Conjugated Estrogens—osteoporosis	0.000674	0.00395	CcSEcCtD
Benzphetamine—Hypersensitivity—Estradiol—osteoporosis	0.000669	0.00393	CcSEcCtD
Benzphetamine—Diarrhoea—Estradiol—osteoporosis	0.000621	0.00365	CcSEcCtD
Benzphetamine—Tamoxifen—ESR2—osteoporosis	0.000613	0.178	CrCbGaD
Benzphetamine—Dizziness—Estradiol—osteoporosis	0.0006	0.00352	CcSEcCtD
Benzphetamine—Headache—Estradiol—osteoporosis	0.000569	0.00334	CcSEcCtD
Benzphetamine—Nausea—Estradiol—osteoporosis	0.000539	0.00316	CcSEcCtD
Benzphetamine—Tamoxifen—CYP19A1—osteoporosis	0.000411	0.119	CrCbGaD
Benzphetamine—Methadone—CYP19A1—osteoporosis	0.000407	0.118	CrCbGaD
Benzphetamine—Tamoxifen—ESR1—osteoporosis	0.000378	0.11	CrCbGaD
Benzphetamine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000159	0.00356	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—AGER—osteoporosis	0.000158	0.00354	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—ADCY5—osteoporosis	0.000157	0.00353	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000153	0.00345	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—CAP1—osteoporosis	0.000153	0.00344	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000151	0.0034	CbGpPWpGaD
Benzphetamine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000148	0.00333	CbGpPWpGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—ADCY5—osteoporosis	0.000148	0.00333	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—CNR2—osteoporosis	0.000145	0.00325	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000145	0.00325	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000139	0.00313	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000134	0.00302	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000134	0.00301	CbGpPWpGaD
Benzphetamine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000129	0.00289	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000127	0.00284	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000124	0.00279	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000122	0.00274	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MGLL—osteoporosis	0.000122	0.00273	CbGpPWpGaD
Benzphetamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00012	0.00269	CbGpPWpGaD
Benzphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.00012	0.00269	CbGpPWpGaD
Benzphetamine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000118	0.00266	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000115	0.00259	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—CYP19A1—osteoporosis	0.000114	0.00255	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000112	0.00252	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PLEK—osteoporosis	0.000111	0.0025	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—ANXA2—osteoporosis	0.000111	0.0025	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CALCR—osteoporosis	0.000104	0.00234	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PTH1R—osteoporosis	0.000104	0.00234	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	9.83e-05	0.00221	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.72e-05	0.00218	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	9.7e-05	0.00218	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—PTH—osteoporosis	9.69e-05	0.00218	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PTH1R—osteoporosis	9.69e-05	0.00218	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CALCR—osteoporosis	9.69e-05	0.00218	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TLN1—osteoporosis	9.6e-05	0.00216	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VCL—osteoporosis	9.47e-05	0.00213	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PTH1R—osteoporosis	9.47e-05	0.00213	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CALCR—osteoporosis	9.47e-05	0.00213	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CNR2—osteoporosis	9.44e-05	0.00212	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—ADCY5—osteoporosis	9.36e-05	0.0021	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—PTH—osteoporosis	9e-05	0.00202	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—WNT1—osteoporosis	8.88e-05	0.00199	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CALCR—osteoporosis	8.8e-05	0.00198	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTH1R—osteoporosis	8.8e-05	0.00198	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CNR2—osteoporosis	8.77e-05	0.00197	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.44e-05	0.0019	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—MGLL—osteoporosis	8.28e-05	0.00186	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—WNT1—osteoporosis	8.25e-05	0.00185	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—PTHLH—osteoporosis	8.03e-05	0.0018	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—RAP1A—osteoporosis	7.91e-05	0.00178	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—ADCY5—osteoporosis	7.72e-05	0.00173	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—MGLL—osteoporosis	7.69e-05	0.00173	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—TGFB1—osteoporosis	7.52e-05	0.00169	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MGLL—osteoporosis	7.52e-05	0.00169	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—PTHLH—osteoporosis	7.46e-05	0.00168	CbGpPWpGaD
Benzphetamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.21e-05	0.00162	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—FGA—osteoporosis	7.18e-05	0.00161	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CALCA—osteoporosis	7.07e-05	0.00159	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MGLL—osteoporosis	6.99e-05	0.00157	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PKM—osteoporosis	6.87e-05	0.00154	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—FDPS—osteoporosis	6.87e-05	0.00154	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—POMC—osteoporosis	6.83e-05	0.00153	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—TGFB1—osteoporosis	6.66e-05	0.0015	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CALCA—osteoporosis	6.57e-05	0.00148	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—FGB—osteoporosis	6.53e-05	0.00147	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GPD2—osteoporosis	6.51e-05	0.00146	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PGLS—osteoporosis	6.51e-05	0.00146	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PKM—osteoporosis	6.44e-05	0.00145	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—FDPS—osteoporosis	6.44e-05	0.00145	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	6.4e-05	0.00144	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SOST—osteoporosis	6.18e-05	0.00139	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GPD2—osteoporosis	6.11e-05	0.00137	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PGLS—osteoporosis	6.11e-05	0.00137	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ATIC—osteoporosis	5.96e-05	0.00134	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PNP—osteoporosis	5.96e-05	0.00134	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.84e-05	0.00131	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SOST—osteoporosis	5.75e-05	0.00129	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	5.73e-05	0.00129	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.68e-05	0.00128	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—POMC—osteoporosis	5.68e-05	0.00127	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CALCR—osteoporosis	5.59e-05	0.00126	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTH1R—osteoporosis	5.59e-05	0.00126	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ATIC—osteoporosis	5.59e-05	0.00125	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PNP—osteoporosis	5.59e-05	0.00125	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PTH—osteoporosis	5.48e-05	0.00123	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CNR2—osteoporosis	5.34e-05	0.0012	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTH1R—osteoporosis	5.2e-05	0.00117	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CALCR—osteoporosis	5.2e-05	0.00117	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.16e-05	0.00116	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.09e-05	0.00114	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PTH—osteoporosis	5.09e-05	0.00114	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—OXCT1—osteoporosis	5.07e-05	0.00114	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CA2—osteoporosis	5.07e-05	0.00114	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.03e-05	0.00113	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PTH—osteoporosis	4.97e-05	0.00112	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	4.96e-05	0.00111	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MGLL—osteoporosis	4.94e-05	0.00111	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.86e-05	0.00109	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CNR2—osteoporosis	4.85e-05	0.00109	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—OXCT1—osteoporosis	4.75e-05	0.00107	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CA2—osteoporosis	4.75e-05	0.00107	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MGLL—osteoporosis	4.63e-05	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTH—osteoporosis	4.62e-05	0.00104	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—WNT1—osteoporosis	4.56e-05	0.00102	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PTHLH—osteoporosis	4.54e-05	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.51e-05	0.00101	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	4.5e-05	0.00101	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MGLL—osteoporosis	4.44e-05	0.000998	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LRP5—osteoporosis	4.34e-05	0.000974	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	4.23e-05	0.000951	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	4.22e-05	0.000947	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—IDH2—osteoporosis	4.2e-05	0.000943	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LRP6—osteoporosis	4.15e-05	0.000932	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MGLL—osteoporosis	4.13e-05	0.000927	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	4.12e-05	0.000926	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LRP5—osteoporosis	4.03e-05	0.000905	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	3.99e-05	0.000897	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP27A1—osteoporosis	3.95e-05	0.000886	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—IDH2—osteoporosis	3.94e-05	0.000884	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LRP6—osteoporosis	3.85e-05	0.000866	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ACP5—osteoporosis	3.84e-05	0.000862	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	3.83e-05	0.00086	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	3.71e-05	0.000834	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP27A1—osteoporosis	3.7e-05	0.000831	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—POMC—osteoporosis	3.7e-05	0.000831	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	3.63e-05	0.000815	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ACP5—osteoporosis	3.6e-05	0.000808	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TPI1—osteoporosis	3.57e-05	0.000802	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TLN1—osteoporosis	3.5e-05	0.000787	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	3.44e-05	0.000772	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—POMC—osteoporosis	3.44e-05	0.000772	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	3.37e-05	0.000757	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—P4HB—osteoporosis	3.36e-05	0.000754	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TPI1—osteoporosis	3.35e-05	0.000752	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GAPDH—osteoporosis	3.29e-05	0.00074	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TLN1—osteoporosis	3.25e-05	0.000731	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—RAP1A—osteoporosis	3.21e-05	0.000721	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—P4HB—osteoporosis	3.15e-05	0.000707	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—POMC—osteoporosis	3.1e-05	0.000697	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GAPDH—osteoporosis	3.09e-05	0.000694	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—P4HB—osteoporosis	3.02e-05	0.000678	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—RAP1A—osteoporosis	3.01e-05	0.000676	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IGF1—osteoporosis	2.96e-05	0.000664	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTH—osteoporosis	2.94e-05	0.00066	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PKM—osteoporosis	2.93e-05	0.000658	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—FDPS—osteoporosis	2.93e-05	0.000658	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	2.89e-05	0.000648	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CNR2—osteoporosis	2.86e-05	0.000643	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.85e-05	0.00064	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	2.84e-05	0.000638	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	2.82e-05	0.000633	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	2.81e-05	0.00063	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DKK1—osteoporosis	2.79e-05	0.000628	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PGLS—osteoporosis	2.78e-05	0.000623	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPD2—osteoporosis	2.78e-05	0.000623	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTH—osteoporosis	2.73e-05	0.000613	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—WNT1—osteoporosis	2.69e-05	0.000605	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	2.68e-05	0.000602	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	2.66e-05	0.000597	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	2.64e-05	0.000593	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGA—osteoporosis	2.62e-05	0.000588	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	2.62e-05	0.000588	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	2.6e-05	0.000583	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ENO1—osteoporosis	2.59e-05	0.000582	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	2.58e-05	0.00058	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PSMA5—osteoporosis	2.56e-05	0.000574	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PSMA2—osteoporosis	2.56e-05	0.000574	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ATIC—osteoporosis	2.54e-05	0.00057	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PNP—osteoporosis	2.54e-05	0.00057	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	2.5e-05	0.000562	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	2.43e-05	0.000547	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BMP2—osteoporosis	2.43e-05	0.000547	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGA—osteoporosis	2.43e-05	0.000546	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ENO1—osteoporosis	2.43e-05	0.000546	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	2.4e-05	0.000539	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PSMA5—osteoporosis	2.4e-05	0.000538	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PSMA2—osteoporosis	2.4e-05	0.000538	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGB—osteoporosis	2.38e-05	0.000535	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	2.3e-05	0.000517	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	2.3e-05	0.000517	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	2.26e-05	0.000508	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	2.26e-05	0.000508	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGB—osteoporosis	2.21e-05	0.000497	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CA2—osteoporosis	2.16e-05	0.000485	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—OXCT1—osteoporosis	2.16e-05	0.000485	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	2.14e-05	0.000481	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	2.14e-05	0.00048	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	2.14e-05	0.00048	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MGLL—osteoporosis	2.1e-05	0.000472	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	2.09e-05	0.000469	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP19A1—osteoporosis	2.07e-05	0.000466	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.99e-05	0.000447	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KL—osteoporosis	1.95e-05	0.000437	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.94e-05	0.000437	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.94e-05	0.000436	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.9e-05	0.000426	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.85e-05	0.000416	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KL—osteoporosis	1.81e-05	0.000406	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—IDH2—osteoporosis	1.79e-05	0.000402	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.77e-05	0.000398	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.76e-05	0.000396	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.72e-05	0.000386	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.69e-05	0.00038	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GPX1—osteoporosis	1.69e-05	0.000379	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.68e-05	0.000378	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ACP5—osteoporosis	1.64e-05	0.000367	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ADCY5—osteoporosis	1.59e-05	0.000357	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GPX1—osteoporosis	1.58e-05	0.000355	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.56e-05	0.00035	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.52e-05	0.000342	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TPI1—osteoporosis	1.52e-05	0.000342	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.47e-05	0.000331	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MTHFR—osteoporosis	1.46e-05	0.000328	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—P4HB—osteoporosis	1.43e-05	0.000321	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.42e-05	0.000318	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.4e-05	0.000315	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.37e-05	0.000308	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.37e-05	0.000307	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.33e-05	0.0003	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.31e-05	0.000293	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.25e-05	0.00028	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—POMC—osteoporosis	1.25e-05	0.00028	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.24e-05	0.000278	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.21e-05	0.000272	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—POMC—osteoporosis	1.17e-05	0.000262	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.16e-05	0.000262	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.16e-05	0.00026	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.12e-05	0.000252	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ENO1—osteoporosis	1.1e-05	0.000248	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.09e-05	0.000246	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.09e-05	0.000245	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.09e-05	0.000245	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.08e-05	0.000243	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.08e-05	0.000242	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.04e-05	0.000234	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.02e-05	0.000228	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1e-05	0.000225	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.83e-06	0.000198	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	8.25e-06	0.000185	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	7.66e-06	0.000172	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ADCY5—osteoporosis	7.22e-06	0.000162	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPX1—osteoporosis	7.19e-06	0.000162	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.64e-06	0.000149	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MYC—osteoporosis	6.48e-06	0.000146	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	6.47e-06	0.000145	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MYC—osteoporosis	6.02e-06	0.000135	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	6.01e-06	0.000135	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—POMC—osteoporosis	5.31e-06	0.000119	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—osteoporosis	4.87e-06	0.000109	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—osteoporosis	4.53e-06	0.000102	CbGpPWpGaD
